Martine Rothblatt's Common Stock Sales in United Therapeutics Corp

The filing details the sale of common stock by Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp. The transactions occurred over the past three months, with multiple sales of 4,000 shares each, totaling significant gross proceeds. The securities were sold through TD Securities (USA) LLC on the NASDAQ exchange. The filing also includes information about the securities to be sold, which were acquired through an Executive Deferred Compensation plan. The notice date for this filing is October 20, 2025, and the plan adoption date is May 2, 2025.